Danaher Co. (NYSE:DHR) Shares Sold by Groupama Asset Managment

Groupama Asset Managment decreased its holdings in Danaher Co. (NYSE:DHR - Free Report) by 7.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,405 shares of the conglomerate's stock after selling 7,769 shares during the quarter. Groupama Asset Managment's holdings in Danaher were worth $27,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. FMR LLC lifted its position in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock valued at $6,566,116,000 after acquiring an additional 3,217,631 shares in the last quarter. Legal & General Group Plc grew its position in Danaher by 2.4% during the second quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock valued at $1,490,112,000 after buying an additional 139,989 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Danaher by 3.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock worth $1,417,342,000 after purchasing an additional 148,251 shares during the period. Fisher Asset Management LLC lifted its position in shares of Danaher by 2.6% during the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock valued at $1,265,725,000 after buying an additional 116,299 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after purchasing an additional 535,254 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

NYSE DHR traded up $1.10 during trading hours on Wednesday, reaching $235.44. The company's stock had a trading volume of 3,370,315 shares, compared to its average volume of 2,781,428. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 1-year low of $218.48 and a 1-year high of $281.70. The company's 50-day moving average is $249.11 and its two-hundred day moving average is $257.94. The firm has a market capitalization of $170.05 billion, a price-to-earnings ratio of 45.09, a P/E/G ratio of 4.23 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business's revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.02 EPS. On average, equities analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date is Friday, December 27th. Danaher's dividend payout ratio (DPR) is 20.61%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on DHR shares. Stifel Nicolaus boosted their target price on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a research report on Wednesday, October 23rd. Stephens restated an "overweight" rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. TD Cowen raised their price target on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Robert W. Baird reduced their price objective on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Finally, Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.